407 related articles for article (PubMed ID: 9072844)
1. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
[TBL] [Abstract][Full Text] [Related]
2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
3. Results of accelerated radiotherapy for supraglottic carcinoma: a Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience.
Nakfoor BM; Spiro IJ; Wang CC; Martins P; Montgomery W; Fabian R
Head Neck; 1998 Aug; 20(5):379-84. PubMed ID: 9663664
[TBL] [Abstract][Full Text] [Related]
4. The role of postradiotherapy neck dissection in supraglottic carcinoma.
Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223
[TBL] [Abstract][Full Text] [Related]
5. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma of the supraglottic larynx without clinically detectable lymph node metastases: problem of local relapse and influence of overall treatment time.
Hoekstra CJ; Levendag PC; van Putten WL
Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):13-21. PubMed ID: 2298616
[TBL] [Abstract][Full Text] [Related]
7. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
[TBL] [Abstract][Full Text] [Related]
8. Recurrence after radiotherapy for glottic carcinoma.
Viani L; Stell PM; Dalby JE
Cancer; 1991 Feb; 67(3):577-84. PubMed ID: 1898708
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for the clinically negative neck in supraglottic laryngeal cancer.
Alpert TE; Morbidini-Gaffney S; Chung CT; Bogart JA; Hahn SS; Hsu J; Kellman RM
Cancer J; 2004; 10(6):335-8. PubMed ID: 15701263
[TBL] [Abstract][Full Text] [Related]
10. 331 cases of clinically node-negative supraglottic carcinoma of the larynx: a study of a modest size fixed field radiotherapy approach.
Sykes AJ; Slevin NJ; Gupta NK; Brewster AE
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1109-15. PubMed ID: 10725620
[TBL] [Abstract][Full Text] [Related]
11. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.
Shimm DS; Coulthard SW
Am J Clin Oncol; 1989 Feb; 12(1):17-23. PubMed ID: 2912019
[TBL] [Abstract][Full Text] [Related]
13. T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy.
Howell-Burke D; Peters LJ; Goepfert H; Oswald MJ
Arch Otolaryngol Head Neck Surg; 1990 Jul; 116(7):830-5. PubMed ID: 2363922
[TBL] [Abstract][Full Text] [Related]
14. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
15. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
Yücetürk AV; Celik O; Eskiizmir G
Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.
Spector JG; Sessions DG; Emami B; Simpson J; Haughey B; Harvey J; Fredrickson JM
Laryngoscope; 1995 Apr; 105(4 Pt 1):397-406. PubMed ID: 7715386
[TBL] [Abstract][Full Text] [Related]
17. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
18. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
19. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
[TBL] [Abstract][Full Text] [Related]
20. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
